This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Circulation problem | |
|---|---|
| Name | Circulation problem |
| Synonyms | Vascular insufficiency; Peripheral circulatory disorder |
| Specialty | Cardiology; Vascular surgery; Internal medicine |
| Symptoms | Cold extremities; Pallor; Claudication; Edema; Cyanosis |
| Complications | Tissue ischemia; Ulceration; Gangrene |
Circulation problem
Circulation problem denotes a range of vascular insufficiencies in which blood flow to tissues is inadequate, producing ischemia, edema, or organ dysfunction. It intersects with clinical fields such as American College of Cardiology, European Society of Cardiology, World Health Organization, Centers for Disease Control and Prevention, and involves health systems like National Health Service (England), Medicare (United States), Mayo Clinic. Understanding draws on research from institutions such as Johns Hopkins Hospital, Cleveland Clinic, Harvard Medical School, Stanford University School of Medicine, and historical advances by figures connected to Andreas Vesalius, William Harvey, Ignaz Semmelweis, Joseph Lister.
Circulation problems encompass disorders of arterial, venous, and microvascular beds affecting perfusion in limbs, organs, or systems and are managed across specialties including Royal College of Physicians, American Heart Association, Society for Vascular Surgery, European Society for Vascular Surgery, and American College of Surgeons. The scope ranges from acute events recognized in settings such as Emergency Medicine departments at centers like Massachusetts General Hospital to chronic conditions addressed in clinics affiliated with Karolinska Institutet and Imperial College London.
Major categories mirror classifications used by bodies like International Classification of Diseases and include arterial insufficiency (acute limb ischemia, chronic peripheral arterial disease), venous disorders (deep vein thrombosis, chronic venous insufficiency, post-thrombotic syndrome), and microcirculatory dysfunction (diabetic microangiopathy, sepsis-associated distributive shock). Subclassifications reference staging systems from organizations such as Global Limb Anatomic Staging System, scoring like the Rutherford classification and interventions guided by guidelines from National Institute for Health and Care Excellence and European Society of Cardiology.
Etiologies derive from a mix of atherosclerotic disease linked to cohorts studied in trials by Framingham Heart Study, thromboembolism seen in registries like International Registry of Acute Aortic Dissection, vasculitis associated with conditions examined at Mayo Clinic, and metabolic contributors characterized in research at National Institutes of Health. Prominent risk factors include smoking documented in campaigns by Campaign for Tobacco-Free Kids, diabetes mellitus prominent in data from International Diabetes Federation, hypertension tracked by World Heart Federation, dyslipidemia studied in Lipid Research Clinics, obesity surveyed in Global Burden of Disease Study, and age trends analyzed by United Nations. Iatrogenic and traumatic causes are reported in series from American College of Surgeons National Surgical Quality Improvement Program.
Clinical features vary: arterial insufficiency may present with acute pain, pulselessness, pallor and poikilothermia noted in case reports from The Lancet and New England Journal of Medicine; chronic arterial disease produces claudication referenced in trials like those by TASC (TransAtlantic Inter-Society Consensus). Venous disease often presents with swelling, hyperpigmentation, and venous ulcers discussed in guidelines from European Wound Management Association and case series from Johns Hopkins Hospital. Systemic presentations include organ dysfunction in septic distributive shock as characterized in Surviving Sepsis Campaign documents and cardiogenic low-output states described in registries such as INTERMACS.
Diagnostic pathways draw on imaging and physiologic testing: duplex ultrasonography protocols from Society for Vascular Ultrasound, computed tomography angiography techniques standardized by Radiological Society of North America, magnetic resonance angiography research from European Society of Radiology, and invasive angiography practiced in catheterization labs like those at Cleveland Clinic. Noninvasive measures include ankle-brachial index endorsed by American Heart Association, transcutaneous oxygen measurements used in studies at Karolinska University Hospital, and biomarkers investigated by European Society of Cardiology and American College of Cardiology research consortia. Risk stratification tools derive from cohorts such as Framingham Heart Study and trials cataloged by ClinicalTrials.gov.
Management encompasses acute revascularization techniques performed by teams at Mayo Clinic and Cleveland Clinic, endovascular interventions guided by Society for Vascular Surgery recommendations, surgical bypass procedures documented by American College of Surgeons, anticoagulation protocols informed by American Society of Hematology, and wound care approaches promoted by American Professional Wound Care Association and European Wound Management Association. Medical therapy includes lipid-lowering agents from evidence in Cholesterol Treatment Trialists' Collaboration, antiplatelet regimens supported by PLATO and CAPRIE trials, diabetes management strategies informed by DCCT and UKPDS, and lifestyle interventions promoted by World Health Organization and United Nations public health initiatives. Rehabilitation and preventive programs are implemented in models evaluated by Centers for Disease Control and Prevention and National Institute for Health and Care Excellence.
Burden estimates derive from studies like the Global Burden of Disease Study and surveillance by World Health Organization and Centers for Disease Control and Prevention, which document prevalence of peripheral arterial disease, venous thromboembolism, and ischemic complications across populations in regions such as Sub-Saharan Africa, South Asia, North America, Europe, and East Asia. Health systems implications affect policy decisions by agencies including National Health Service (England), Centers for Medicare & Medicaid Services, and funding bodies like National Institutes of Health. Prevention programs align with campaigns by World Heart Federation, tobacco control by World Health Organization Framework Convention on Tobacco Control, and diabetes initiatives by International Diabetes Federation. Socioeconomic disparities highlighted in reports from World Bank and Organisation for Economic Co-operation and Development influence incidence, access to limb-salvage care, and outcomes across patient populations.
Category:Vascular diseases